FI875086A - Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents

Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. Download PDF

Info

Publication number
FI875086A
FI875086A FI875086A FI875086A FI875086A FI 875086 A FI875086 A FI 875086A FI 875086 A FI875086 A FI 875086A FI 875086 A FI875086 A FI 875086A FI 875086 A FI875086 A FI 875086A
Authority
FI
Finland
Prior art keywords
benzotiadiazinfoereningar
nya
foerfarande foer
deras framstaellning
framstaellning och
Prior art date
Application number
FI875086A
Other languages
English (en)
Other versions
FI875086A0 (fi
Inventor
Teruo Oku
Eishiro Todo
Chiyoshi Kasahara
Katsuya Nakamura
Hiroshi Kayakiri
Masashi Hashimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868627857A external-priority patent/GB8627857D0/en
Priority claimed from GB878714598A external-priority patent/GB8714598D0/en
Priority claimed from GB878720659A external-priority patent/GB8720659D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI875086A0 publication Critical patent/FI875086A0/fi
Publication of FI875086A publication Critical patent/FI875086A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI875086A 1986-11-21 1987-11-18 Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. FI875086A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868627857A GB8627857D0 (en) 1986-11-21 1986-11-21 Benzothiadiazine compounds
GB878714598A GB8714598D0 (en) 1987-06-22 1987-06-22 Benzothiadiazine compounds
GB878720659A GB8720659D0 (en) 1987-09-02 1987-09-02 Benzothiadiazine compounds

Publications (2)

Publication Number Publication Date
FI875086A0 FI875086A0 (fi) 1987-11-18
FI875086A true FI875086A (fi) 1988-05-22

Family

ID=27263212

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875086A FI875086A (fi) 1986-11-21 1987-11-18 Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.

Country Status (9)

Country Link
US (1) US4889851A (fi)
EP (1) EP0268990A3 (fi)
JP (1) JP2564860B2 (fi)
KR (1) KR880006219A (fi)
CN (1) CN87107990A (fi)
AU (1) AU603842B2 (fi)
DK (1) DK597387A (fi)
FI (1) FI875086A (fi)
NO (1) NO874850L (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223237A (en) * 1987-01-22 1991-03-26 Shiseido Co Ltd Hair growth promoting agent and compositions
WO1994017075A1 (en) * 1993-01-20 1994-08-04 A. Menarini Industrie Farmaceutiche Riunite S.R.L. Diazepin derivatives and antiviral compositions
FR2710062B1 (fr) * 1993-09-17 1995-12-01 Rhone Poulenc Rorer Sa Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.
US6008208A (en) 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
HUP9802319A3 (en) * 1995-10-23 1999-12-28 Zymogenetics Inc Seattle Pharmaceutical compositions for treatment of bone deficit conditions
WO1998017267A1 (en) * 1996-10-23 1998-04-30 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
CA2271116A1 (en) * 1996-11-13 1998-05-22 Gregory J. Wells Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
US5952328A (en) * 1997-11-12 1999-09-14 Cephalon, Inc. Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
JP2002543163A (ja) 1999-04-30 2002-12-17 スリル バイオメディカル コーポレイション 癌および前立腺疾患のための治療としての結合体
MXPA03004965A (es) * 2000-12-16 2003-09-25 Aventis Pharma Gmbh El uso de heparina de bajo peso molecular para el tratamiento de osteoartrosis.
IL161428A0 (en) * 2001-10-16 2004-09-27 Slil Biomedical Corp Oligoamine derivatives, methods for the production thereof and pharmaceutical compositions containing the same
KR100787130B1 (ko) * 2006-03-23 2007-12-21 한국화학연구원 신규의 치환된 1,1-다이옥소-벤조[1,2,4]티아디아진-3-온, 이의 제조방법 및 이를 포함하는 약학적 조성물
UA100120C2 (en) * 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. 5,6-dihydro-1h-pyridin-2-one compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296070A (en) * 1967-01-03 Method for the treatment of hypertension
DE1067028B (fi) * 1959-10-15
US3287362A (en) * 1966-11-22 Substituted j-oxo-j,x-dihydro-l,z,x-benzo- thiadiazine i,i-dioxides and a method for their preparation
US3267096A (en) * 1965-02-24 1966-08-16 Miles Lab Derivatives of 2h, 4h-benzothiadiazine 1, 1-dioxide
FR5571M (fi) * 1965-12-23 1967-11-27
US3892738A (en) * 1972-03-20 1975-07-01 Merck & Co Inc 7-Thiasubstituted-1,2,4-benzothiadiazine-1,1-dioxides and their salts
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives

Also Published As

Publication number Publication date
DK597387D0 (da) 1987-11-13
EP0268990A3 (en) 1988-08-10
KR880006219A (ko) 1988-07-22
AU8146587A (en) 1988-05-26
FI875086A0 (fi) 1987-11-18
DK597387A (da) 1988-05-22
JP2564860B2 (ja) 1996-12-18
EP0268990A2 (en) 1988-06-01
NO874850D0 (no) 1987-11-20
US4889851A (en) 1989-12-26
AU603842B2 (en) 1990-11-29
CN87107990A (zh) 1988-06-01
NO874850L (no) 1988-05-24
JPS63183572A (ja) 1988-07-28

Similar Documents

Publication Publication Date Title
FI860971A0 (fi) Nya sulfonylaminoetylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI862623A (fi) Nya 2-arylimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI874323A (fi) Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI864879A0 (fi) Nya tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.
FI861153A0 (fi) Nya jodpropargyletrar, foerfarande foer deras framstaellning och deras anvaendning.
FI872841A (fi) Nya kromoforfoereningar, solskyddskompositioner och foerfarande foer hindrande av solbraenna.
FI870274A0 (fi) Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster.
FI875719A0 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI883347A (fi) Nya 5-aminometylen-2,4 -imidazolidindioner och 5-aminometylen-4-tionoimidazolidin-4-oner.
FI875086A0 (fi) Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI872897A0 (fi) Nya 4-pyridonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI862723A (fi) Nya sackarider, deras framstaellning och farmaceutiska sammansaettningar innehaollande desamma.
FI885056A0 (fi) Nya fluormetoxifenyldihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI885722A0 (fi) Nya kinolinderivat, foerfaranden foer framstaellning daerav och antibakteriella aemnen innehaollande desamma.
FI884225A (fi) Nya aminosyraestrar, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI871812A (fi) Nya benzotiazinonderivat, deras framstaellningsfoerfarande dessa innehaollande laekemedel och deras anvaendning.
FI865190A (fi) Nya bensamider, foerfarande foer deras framstaellning och deras terapeutiska anvaendning.
FI875212A0 (fi) Nya aryloxi-3-amino-2-propanoler, deras framstaellning och anvaendning.
FI862970A (fi) Nya 11-metylen-estr-15-ener, foerfaranden foer deras framstaellning och farmaceutiska kompositioner.
FI874172A0 (fi) Nya aryloxi-aminoalkaner, deras framstaellning och anvaendning.
FI885057A (fi) Nya fluormetoxifenyldihydropyridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel.
FI870435A0 (fi) Nya 2-amino-3-formyl-furaner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI873179A (fi) Nya tetrahydrobenzotiazolo-kinoliner, deras framstaellning och anvaendning.
FI874602A (fi) Nya jaestexpressionvektor foer ifn-omega, foerfarande foer deras framstaellning och deras anvaendning.
FI894315A0 (fi) Nya sulfonamider, foerfarande foer deras framstaellning och dessa nya sulfonamider innehaollande farmaceutiska kompositioner.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.